The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.99 billion
P/E Ratio 26.18
Dividend Yield 0.00%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share N/A
Year To Date Return 27.93%
Earnings Yield 3.82%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    a woman
    Growth Shares

    3 ASX growth shares to buy and hold for the next decade

    I think these 3 ASX growth shares could be 3 of the best ideas to buy and hold for the…

    Read more »

    a woman
    Share Market News

    3 ASX growth shares to buy and hold beyond 2025

    Here's why I think these 3 ASX growth shares are great options to buy and hold until 2025 and beyond.

    Read more »

    a woman
    Growth Shares

    2 of the best ASX growth shares to buy for 2020

    If I were investing in ASX growth shares, I’d choose one of these 2 ideas including A2 Milk Company Ltd…

    Read more »

    a woman
    Share Market News

    Forget a2 Milk! Why these 3 ASX baby formula stocks could soar in 2020

    Why Nuchev Ltd (ASX: NUC), Clover Corporation Ltd (ASX: CLV) and Keytone Dairy Corporation Ltd (ASX: KTD) could be speculative…

    Read more »

    a woman
    Growth Shares

    Where to invest $10,000 in ASX shares right now

    Here's why I would invest $10,000 into the shares of Afterpay Ltd (ASX:APT) and these fast-growing companies in January...

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes lower Monday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished down on Monday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Gainers

    2 ASX shares exposed to China's growth

    Below are two ASX companies which have managed to ride the coat tails of the soaring Chinese middle class, banking…

    Read more »

    a woman
    Share Market News

    A2 Milk Company announces more senior leadership changes

    The A2 Milk Company Ltd (ASX:A2M) share price is on the move on Monday after announcing more senior leadership changes...

    Read more »

    a woman
    Share Gainers

    Is this infant formula company the next a2 Milk Company?

    Is Nuchev Limited (ASX:NUC) the next A2 Milk Company Ltd (ASX:A2M)?

    Read more »

    a woman
    How to invest

    ASX industries to include in your portfolio for diversification

    Variety may be the spice of life, but it’s also an investment fundamental. Different industries respond differently to changes in…

    Read more »

    a woman
    Growth Shares

    3 stellar ASX growth shares to buy in January

    a2 Milk Company Ltd (ASX:A2M) is one of three ASX shares I think growth investors ought to buy in January...

    Read more »

    a woman
    How to invest

    How do you know when it's time to invest?

    We all hear a lot about investing, but how do you know when it’s the right time? Work through this…

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    25 Nov 2024 $5.51 $0.06 1.10% 3,677,782 $5.50 $5.68 $5.45
    22 Nov 2024 $5.45 $0.64 13.31% 10,716,572 $5.59 $5.72 $5.38
    21 Nov 2024 $4.81 $-0.05 -1.03% 1,965,985 $4.88 $4.88 $4.81
    20 Nov 2024 $4.86 $-0.05 -1.02% 1,458,109 $4.92 $4.93 $4.82
    19 Nov 2024 $4.91 $-0.01 -0.20% 1,127,277 $4.93 $4.96 $4.89
    18 Nov 2024 $4.92 $0.11 2.29% 2,061,480 $4.82 $4.94 $4.79
    15 Nov 2024 $4.81 $-0.09 -1.84% 1,855,320 $4.92 $4.95 $4.80
    14 Nov 2024 $4.90 $0.12 2.51% 2,529,308 $4.78 $4.90 $4.76
    13 Nov 2024 $4.78 $-0.04 -0.83% 3,425,795 $4.80 $4.87 $4.73
    12 Nov 2024 $4.82 $-0.10 -2.03% 6,595,003 $4.95 $4.95 $4.77
    11 Nov 2024 $4.92 $-0.36 -6.82% 5,608,810 $5.30 $5.30 $4.89
    08 Nov 2024 $5.28 $0.09 1.73% 3,614,439 $5.23 $5.29 $5.14
    07 Nov 2024 $5.19 $-0.13 -2.44% 4,171,502 $5.26 $5.29 $5.19
    06 Nov 2024 $5.32 $-0.16 -2.92% 2,402,885 $5.46 $5.50 $5.32
    05 Nov 2024 $5.48 $-0.11 -1.97% 2,911,127 $5.56 $5.57 $5.39
    04 Nov 2024 $5.59 $-0.12 -2.10% 2,148,664 $5.70 $5.71 $5.56
    01 Nov 2024 $5.71 $-0.06 -1.04% 1,122,735 $5.70 $5.78 $5.69
    31 Oct 2024 $5.77 $0.02 0.35% 1,983,122 $5.73 $5.84 $5.68
    30 Oct 2024 $5.75 $-0.08 -1.37% 1,646,474 $5.90 $5.91 $5.75
    29 Oct 2024 $5.83 $0.10 1.75% 5,071,981 $5.79 $5.98 $5.78

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
    Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
    Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note